Japan Cancer Diagnostics Market Expected to Reach USD 3.6 Billion by 2033 - IMARC Group

January 28, 2025 | Healthcare

VIEW FULL TABLE OF CONTENTS

Japan Cancer Diagnostics Market Statistics, Outlook and Regional Analysis 2025-2033

The Japan cancer diagnostics market size was valued at USD 1.3 Billion in 2024, and it is expected to reach USD 3.6 Billion by 2033, exhibiting a growth rate (CAGR) of 12.2% from 2025 to 2033.

Japan Cancer Diagnostics Market

To get more information on this market, Request Sample

The rising inclination towards precision medicine, along with the incidences of cancer, has pushed the demand for advanced technology in cancer diagnostics across Japan. Supporting this trend, healthcare providers are substantially investing in research for the early identification and targeted treatments by collaborating with biotechnology corporations and diagnostic companies. These trends are further supported by strategic alliances that aim to use innovative technologies to enhance diagnostic capabilities. For example, Hitachi High-Tech and Gencurix declared a partnership to enhance cancer molecular diagnostics in August 2024. Individualized diagnostic testing services are commercialized in Japan by combining learning of digital technology and biomarker discoveries through this partnership. Their efforts are anticipated to advance in vitro diagnostics and innovative molecular testing solutions, ensuring more accurate and efficient cancer detection and treatment.

Besides this, Japan's National Cancer Center, PREMIA, ventured LC-SCRUM in November 2024, a nationwide clinical trial network that utilizes genomic screening across 150+ hospitals. This program seeks to increase access to precision medicine to meet the country's growing need for patient-specific cancer care. Moreover, the ongoing integration of genetic profiling in clinical settings is impelling the market. Increasing the efficacy of targeted therapies and companion diagnostics advancements allows to identification of genetic alterations with accuracy. For instance, Chugai obtained Japanese approval for FoundationOne CDx as a companion diagnostic for capivasertib in March 2024. This approval marked a significant step with PIK3CA, AKT1, or PTEN mutations. Patients with advanced HR-positive and HER2-negative breast cancer can get precision treatment, which represents a major advancement in genomic profiling. This development underscores the growing role of companion diagnostics in developing tailored cancer care with the potential to help over half of the afflicted patient population.

Japan Cancer Diagnostics Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Kanto region, Kansai/Kinki region, Central/ Chubu region, Kyushu-Okinawa region, Tohoku region, Chugoku region, Hokkaido region, and Shikoku region. The widespread emphasis on detecting cancer at an early stage, along with the rising awareness campaigns, is elevating the market.

Kanto Region Cancer Diagnostics Market Trends:

The Kanto region is experiencing rapid growth in integrating advanced cancer diagnostic technologies. Research centers are focusing on precision medicine, using genomic profiling for tailored therapies. Also, AI-powered imaging systems, which are broadly used in Tokyo as well as Saitama, further improve the early diagnosis of colorectal and lung malignancies. Clinical trials provide ease of accessibility for patients to advanced diagnostic technologies, and public-private partnerships further spur innovation.

Kansai/Kinki Region Cancer Diagnostics Market Trends:

The Kansai region is advancing in biomarker-based cancer diagnostics, which is positively impacting the industry's growth. Osaka University spearheads research on non-invasive methods for detecting pancreatic and liver tumors. Correspondingly, Kyoto's medical facilities are using AI-driven research to enhance imaging to pre-phase cancer detection. Government-led awareness campaigns in prefectures like Hyogo encourage routine screenings, boosting early diagnosis rates and contributing to improved patient outcomes across the region.

Central/Chubu Region Cancer Diagnostics Market Trends:

In the Chubu region, led by Nagoya, AI technologies dominate the cancer diagnostics market. Hospitals like Nagoya University Hospital employ machine learning to improve diagnostic accuracy in breast and colorectal cancers. Partnerships with startups are fostering the development of AI-powered imaging tools. Counties like Shizuoka are benefiting from streamlined diagnostic workflows, enabling faster identification and treatment planning, particularly in underserved rural areas.

Kyushu-Okinawa Region Cancer Diagnostics Market Trends:

The Kyushu-Okinawa region places a substantial focus on cancer diagnostics with breakthroughs such as liquid biopsy. Fukuoka hospitals are using these non-invasive techniques to recognize ovarian and prostate malignancies early on. Concurrent with this, Okinawan healthcare providers are implementing portable diagnostic equipment to improve accessibility in outlying locations. Patients are receiving more individualized therapy options because of the regional partnerships with biotech companies that are advancing targeted diagnostics research.

Tohoku Region Cancer Diagnostics Market Trends:

The Tohoku region concentrates on the integration of advanced imaging technology for cancer diagnosis. In response to these dynamics, hospitals in counties like Miyagi are utilizing high-resolution radiological technologies to boost the accuracy of detecting malignancies that are difficult to detect, like ovarian and pancreatic cancers. Apart from that, AI-assisted diagnostics are implemented in rural clinics through associations with international digital businesses, thereby reducing healthcare gaps and strengthening early detection initiatives throughout the region.

Chugoku Region Cancer Diagnostics Market Trends:

Molecular diagnostics innovation is augmenting the market in the Chugoku region which is the home to Hiroshima. Also, Hiroshima University cooperates with regional biotech enterprises to provide DNA-based testing for malignancies like lymphoma and leukemia. Not only that, but these technologies are also integrated into public health systems in counties like Yamaguchi, thereby expanding access to reasonably inexpensive and pocket-friendly testing.

Hokkaido Region Cancer Diagnostics Market Trends:

Hokkaido focuses on increasing accessibility to cancer diagnostics, especially for its rural and aging population. Sapporo hospitals lead in mobile diagnostic unit deployment, offering screenings for breast and cervical cancers. Countries like Kushiro integrate community-based programs, promoting awareness and early detection. Advances in portable imaging technologies have also facilitated real-time diagnostics in remote areas, ensuring equitable healthcare services across the region.

Shikoku Region Cancer Diagnostics Market Trends:

The Shikoku region, with Matsuyama as a key city, emphasizes training healthcare professionals in advanced cancer diagnostics. Ehime University spearheads programs to equip medical staff with expertise in genomic testing and AI-enhanced imaging. Countries like Kagawa are adopting these innovations to improve diagnostic capabilities in local clinics. Collaborative efforts between academia and hospitals ensure that Shikoku stays competitive in providing cutting-edge diagnostic solutions.

Top Companies Leading in the Japan Cancer Diagnostics Industry

The report reflects their innovations, market impact, and contributions to the sector. Hitachi High-Tech and Gencurix declared a partnership to enhance cancer molecular diagnostics in August 2024. Individualized diagnostic testing services are commercialized in Japan by combining learning of digital technology and biomarker discoveries through this partnership. Besides this, Chugai obtained Japanese approval for FoundationOne CDx as a companion diagnostic for capivasertib in March 2024.

Japan Cancer Diagnostics Market Segmentation Coverage

On the basis of the product, the market has been bifurcated into consumables (antibodies, kits and reagents, probes, and others) and instruments (pathology-based instruments, imaging instruments, and biopsy instruments). Consumables like reagents and instruments such as analyzers play a critical role in cancer diagnostics by enabling accurate sample processing, biomarker identification, and real-time detection for improved disease management.
Based on the technology, the market is categorized into IVD testing (polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next-generation sequencing (NGS), microarrays, flow cytometry, immunoassays, and others), imaging (magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, and ultrasound), and biopsy technique. Advanced cancer diagnostics utilize in vitro diagnostics, imaging technologies like CT and PET scans, and biopsy techniques to detect, localize, and evaluate malignancies with precision, aiding in timely and personalized treatment strategies.
On the basis of the application, the market has been divided into breast cancer, lung cancer, colorectal cancer, melanoma, and others. Cancer diagnostics focus on identifying and monitoring breast, lung, colorectal, melanoma, and other cancers through targeted testing methods, enabling early detection, staging, and the development of effective treatment protocols.
Based on the end user, the market is categorized into hospitals and clinics, diagnostic laboratories, and others. Cancer diagnostics rely on these institutions as primary providers of screening and detection services, ensuring accessible and accurate testing environments for improved patient outcomes.

Report Features	Details
Market Size in 2024	USD 1.3 Billion
Market Forecast in 2033	USD 3.6 Billion
Market Growth Rate 2025-2033	12.2%
Units	Billion USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Product Technology Application End User Region
Products Covered	Consumables: Antibodies, Kits and Reagents, Probes, Others Instruments: Pathology-based Instruments, Imaging Instruments, Biopsy Instruments
Technologies Covered	IVD Testing: Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-generation Sequencing (NGS), Microarrays, Flow Cytometry, Immunoassays, Others Imaging: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Mammography, Ultrasound Biopsy Technique
Applications Covered	Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Others
End Users Covered	Hospitals and Clinics, Diagnostic Laboratories, Others
Regions Covered	Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Browse IMARC Related Reports on Cancer Diagnostics Market:

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Japan Cancer Diagnostics Market Expected to Reach USD 3.6 Billion by 2033 - IMARC Group

Purchase Options Discount
Offer

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.